468 related articles for article (PubMed ID: 30692991)
21. Combining Radiotherapy With Anti-angiogenic Therapy and Immunotherapy; A Therapeutic Triad for Cancer?
Goedegebuure RSA; de Klerk LK; Bass AJ; Derks S; Thijssen VLJL
Front Immunol; 2018; 9():3107. PubMed ID: 30692993
[TBL] [Abstract][Full Text] [Related]
22. Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy.
Chen S; Lai SWT; Brown CE; Feng M
Front Immunol; 2021; 12():635173. PubMed ID: 33790906
[TBL] [Abstract][Full Text] [Related]
23. Nanoengineered Disruption of Heat Shock Protein 90 Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer.
Smalley M; Natarajan SK; Mondal J; Best D; Goldman D; Shanthappa B; Pellowe M; Dash C; Saha T; Khiste S; Ramadurai N; Eton EO; Smalley JL; Brown A; Thayakumar A; Rahman M; Arai K; Kohandel M; Sengupta S; Goldman A
Cancer Res; 2020 Dec; 80(23):5355-5366. PubMed ID: 33077554
[TBL] [Abstract][Full Text] [Related]
24. Diverse macrophages polarization in tumor microenvironment.
Rhee I
Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
[TBL] [Abstract][Full Text] [Related]
25. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
Darragh LB; Oweida AJ; Karam SD
Front Immunol; 2018; 9():3154. PubMed ID: 30766539
[TBL] [Abstract][Full Text] [Related]
26. Histamine in cancer immunology and immunotherapy. Current status and new perspectives.
Sarasola MP; Táquez Delgado MA; Nicoud MB; Medina VA
Pharmacol Res Perspect; 2021 Oct; 9(5):e00778. PubMed ID: 34609067
[TBL] [Abstract][Full Text] [Related]
27. The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions?
Jacobs B; Ullrich E
Curr Med Chem; 2012; 19(12):1771-9. PubMed ID: 22414086
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
[TBL] [Abstract][Full Text] [Related]
29. Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model.
Wu J; Waxman DJ
Cancer Lett; 2014 Oct; 353(2):272-80. PubMed ID: 25069038
[TBL] [Abstract][Full Text] [Related]
30. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
[TBL] [Abstract][Full Text] [Related]
31. Ginseng (Panax ginseng Meyer) oligopeptides regulate innate and adaptive immune responses in mice via increased macrophage phagocytosis capacity, NK cell activity and Th cells secretion.
He LX; Ren JW; Liu R; Chen QH; Zhao J; Wu X; Zhang ZF; Wang JB; Pettinato G; Li Y
Food Funct; 2017 Oct; 8(10):3523-3532. PubMed ID: 28875201
[TBL] [Abstract][Full Text] [Related]
32. Biopolymer Immune Implants' Sequential Activation of Innate and Adaptive Immunity for Colorectal Cancer Postoperative Immunotherapy.
Ji G; Zhang Y; Si X; Yao H; Ma S; Xu Y; Zhao J; Ma C; He C; Tang Z; Fang X; Song W; Chen X
Adv Mater; 2021 Jan; 33(3):e2004559. PubMed ID: 33296110
[TBL] [Abstract][Full Text] [Related]
33. Effects of Radiation on the Tumor Microenvironment.
Monjazeb AM; Schalper KA; Villarroel-Espindola F; Nguyen A; Shiao SL; Young K
Semin Radiat Oncol; 2020 Apr; 30(2):145-157. PubMed ID: 32381294
[TBL] [Abstract][Full Text] [Related]
34. From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy.
Deng L; Liang H; Fu S; Weichselbaum RR; Fu YX
Clin Cancer Res; 2016 Jan; 22(1):20-5. PubMed ID: 26362999
[TBL] [Abstract][Full Text] [Related]
35. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
36. Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types.
van den Ende T; van den Boorn HG; Hoonhout NM; van Etten-Jamaludin FS; Meijer SL; Derks S; de Gruijl TD; Bijlsma MF; van Oijen MGH; van Laarhoven HWM
Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188386. PubMed ID: 32540465
[TBL] [Abstract][Full Text] [Related]
37. Regulation of tumor infiltrated innate immune cells by adenosine.
Strakhova R; Cadassou O; Cros-Perrial E; Jordheim LP
Purinergic Signal; 2020 Sep; 16(3):289-295. PubMed ID: 32529478
[TBL] [Abstract][Full Text] [Related]
38. Targeting innate sensing in the tumor microenvironment to improve immunotherapy.
Liu Z; Han C; Fu YX
Cell Mol Immunol; 2020 Jan; 17(1):13-26. PubMed ID: 31844141
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
40. Immune response regulation in the tumor microenvironment by hypoxia.
Labiano S; Palazon A; Melero I
Semin Oncol; 2015 Jun; 42(3):378-86. PubMed ID: 25965356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
